Bruker (BRKRP) EBT Margin (2010 - 2026)
Bruker posted quarterly EBT Margin of 2.66% for Q1 2026, down 47.0% year-on-year from 5.02% in Q1 2025, and down 76.11% on a QoQ basis from 11.13% in Q4 2025.
Bruker (BRKRP) has 17 years of EBT Margin data on file, last reported at 2.66% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 47.0% year-over-year to 2.66%; the trailing twelve-month figure through Mar 2026 stood at 779.37% (down 78402.0% YoY), and the FY2025 full-year result was 1655.73%, down 166188.0% from the prior year.
- EBT Margin for Q1 2026 stood at 2.66%, down from 11.13% in the prior quarter.
- Across five years, EBT Margin topped out at 28.11% in Q4 2023 and bottomed at 8.34% in Q3 2025.
- The 5-year median for EBT Margin is 11.13% (2025), against an average of 10.09%.
- The widest annual swing landed in 2023, when EBT Margin soared 915 bps; it then tumbled 2238 bps in 2024.
- A 5-year view of EBT Margin shows it stood at 18.96% in 2022, then jumped by 48 bps to 28.11% in 2023, then tumbled by 80 bps to 5.73% in 2024, then soared by 94 bps to 11.13% in 2025, then slumped by 76 bps to 2.66% in 2026.
- The last three EBT Margin figures came in at 2.66% (Q1 2026), 11.13% (Q4 2025), and 8.34% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Bruker | - | - | 379.80 Mn | 2.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.66% |
| Dec 31, 2025 | 11.13% |
| Sep 30, 2025 | -8.34% |
| Jun 30, 2025 | 0.06% |
| Mar 31, 2025 | 3.13% |
| Dec 31, 2024 | 5.73% |
| Sep 30, 2024 | 6.40% |
| Jun 30, 2024 | 2.98% |
| Mar 31, 2024 | 9.92% |
| Dec 31, 2023 | 28.11% |
| Sep 30, 2023 | 16.05% |
| Jun 30, 2023 | 11.37% |
| Mar 31, 2023 | 15.56% |
| Dec 31, 2022 | 18.96% |
| Sep 30, 2022 | 20.24% |
| Jun 30, 2022 | 11.83% |
| Mar 31, 2022 | 15.80% |
| Dec 31, 2021 | 19.74% |
| Sep 30, 2021 | 17.87% |
| Jun 30, 2021 | 14.02% |
| Mar 31, 2021 | 15.38% |
| Dec 31, 2020 | 21.80% |
| Sep 30, 2020 | 14.72% |
| Jun 30, 2020 | 7.37% |
| Mar 31, 2020 | 3.18% |
| Dec 31, 2019 | 18.54% |
| Sep 30, 2019 | 15.97% |
| Jun 30, 2019 | 9.71% |
| Mar 31, 2019 | 8.32% |
| Dec 31, 2018 | 20.88% |
| Sep 30, 2018 | 14.02% |
| Jun 30, 2018 | 9.76% |
| Mar 31, 2018 | 8.29% |
| Dec 31, 2017 | 16.70% |
| Sep 30, 2017 | 10.88% |
| Jun 30, 2017 | 7.28% |
| Mar 31, 2017 | 8.21% |
| Dec 31, 2016 | 18.80% |
| Sep 30, 2016 | 10.92% |
| Jun 30, 2016 | 4.79% |
| Mar 31, 2016 | 7.57% |
| Dec 31, 2015 | -6.09% |
| Sep 30, 2015 | 5.96% |
| Jun 30, 2015 | 6.41% |
| Mar 31, 2015 | 3.31% |
| Dec 31, 2014 | 8.56% |
| Sep 30, 2014 | 2.14% |
| Jun 30, 2014 | 7.24% |
| Mar 31, 2014 | 3.71% |
| Dec 31, 2013 | 9.74% |
| Sep 30, 2013 | 6.10% |
| Jun 30, 2013 | 7.85% |
| Mar 31, 2013 | 2.11% |
| Dec 31, 2012 | 8.91% |
| Sep 30, 2012 | 12.86% |
| Jun 30, 2012 | 4.59% |
| Mar 31, 2012 | 6.63% |
| Dec 31, 2011 | 16.35% |
| Sep 30, 2011 | 9.42% |
| Jun 30, 2011 | 8.23% |
| Mar 31, 2011 | 5.80% |
| Dec 31, 2010 | -26.68% |
| Sep 30, 2010 | 12.31% |
| Jun 30, 2010 | 11.20% |
| Mar 31, 2010 | 9.58% |